23 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Oct 2032. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2032
Next term end
14
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than Oct 2032 · Medium confidence
Also notable
Ends Nov 2040 · High confidence
Also notable
Ends Jun 2039 · High confidence
Methods for Sensing or Stimulating Activity of Tissue
US 10,575,783
The most cited patent in this portfolio, cited by 56 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2032. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Methods, Systems, and Apparatus for Closed-Loop Neuromodulation
US 11,672,986
Cited by 10 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2040. A terminal disclaimer caps this term to an earlier patent's.
Systems and Methods for Generic Control Using a Neural Signal
US 11,755,110
Cited by 12 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2039. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 13, 2026The maintenance fee for Methods, Systems, and Apparatus for Closed-Loop Neuromodulation (US 11,672,986) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Systems and Methods for Generic Control Using a Neural Signal (US 11,755,110) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Methods, Systems, and Apparatus for Closed-Loop Neuromodulation (US 11,883,671) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
- 1 fee due Sep 3, 2027The maintenance fee for Methods for Sensing or Stimulating Activity of Tissue (US 10,575,783) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 19, 2026
What they patent
The 5 largest of its 14 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Systems and Methods for Increasing Control Using a Neural Signal | 3 in force | to Aug 2042 |
| Methods, Systems, and Apparatus for Closed-Loop Neuromodulation | 3 in force | to Nov 2040 |
| Systems and Methods for Configuring a Brain Control Interface Using Data from Deployed Systems | 3 in force | to Oct 2040 |
| Systems and Methods for Generic Control Using a Neural Signal | 2 in force | to Jan 2043 |
| Systems and Methods for Controlling a Device Using Detected Changes in a Neural-Related Signal | 2 in force | to Apr 2041 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,575,783 | Methods for Sensing or Stimulating Activity of Tissue In force · Medium confidence | In force | Medium confidence | |
| US 11,093,038 | Systems and Methods for Generic Control Using a Neural Signal In force · High confidence | In force | High confidence | |
| US 11,755,110 | Systems and Methods for Generic Control Using a Neural Signal In force · High confidence | In force | High confidence | |
| US 11,625,014 | Systems and Methods for Configuring a Brain Control Interface Using Data from Deployed Systems In force · High confidence | In force | High confidence | |
| US 12,032,345 | Systems and Methods for Configuring a Brain Control Interface Using Data from Deployed Systems In force · High confidence | In force | High confidence | |
| US 12,455,543 | Systems and Methods for Configuring a Brain Control Interface Using Data from Deployed Systems In force · High confidence | In force | High confidence | |
| US 11,672,986 | Methods, Systems, and Apparatus for Closed-Loop Neuromodulation In force · High confidence | In force | High confidence | |
| US 11,883,671 | Methods, Systems, and Apparatus for Closed-Loop Neuromodulation In force · High confidence | In force | High confidence | |
| US 12,168,135 | Methods, Systems, and Apparatus for Closed-Loop Neuromodulation In force · High confidence | In force | High confidence | |
| US 11,550,391 | Systems and Methods for Controlling a Device Using Detected Changes in a Neural-Related Signal In force · High confidence | In force | High confidence |
Also on record, not counted in the 23: 29 applications pending · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.